Lopid Patent Term Restoration and Fairness Act of 1987: Hearing Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, First Session, October 8, 1987, Volume 4U.S. Government Printing Office, 1988 - 350 pages |
From inside the book
Results 1-5 of 43
Page 93
... observed , and there were no changes in blood glucose , glucose tolerance , or serum insulin concentrations . Gemfibrozil has been shown to lower serum triglyceride levels as well as raising high density lipoprotein ( HDL ) -cholesterol ...
... observed , and there were no changes in blood glucose , glucose tolerance , or serum insulin concentrations . Gemfibrozil has been shown to lower serum triglyceride levels as well as raising high density lipoprotein ( HDL ) -cholesterol ...
Page 100
... observed in obese patients with Type 2 diabetes during body weight reduction ( Vessby and Lithell , in press ) . An additional question addressed in the present study was whether gemfibrozil significantly affects the plasma lipid ester ...
... observed in obese patients with Type 2 diabetes during body weight reduction ( Vessby and Lithell , in press ) . An additional question addressed in the present study was whether gemfibrozil significantly affects the plasma lipid ester ...
Page 107
... observed in HDL - cholesterol seemed to contribute to the reduction in heart disease incidence . Further Progress with Gemfibrozil , edited by C. Wood , 1986 : Royal Society of Medicine Services International Congress and Symposium ...
... observed in HDL - cholesterol seemed to contribute to the reduction in heart disease incidence . Further Progress with Gemfibrozil , edited by C. Wood , 1986 : Royal Society of Medicine Services International Congress and Symposium ...
Page 111
... observed in the patients with familial hyper- cholesterolaemia were similar , and possibly greater , than those observed in the entire group ( Table 2 ) . The average maximum decrease in LDL - cholesterol was about 11 per cent , and the ...
... observed in the patients with familial hyper- cholesterolaemia were similar , and possibly greater , than those observed in the entire group ( Table 2 ) . The average maximum decrease in LDL - cholesterol was about 11 per cent , and the ...
Page 115
... observed during the 15 months of this study are shown in Table 1. HDL - cholesterol increased , while total ... observed after 1 month of treatment . During the second placebo period , apo A - I remained at the level reached during ...
... observed during the 15 months of this study are shown in Table 1. HDL - cholesterol increased , while total ... observed after 1 month of treatment . During the second placebo period , apo A - I remained at the level reached during ...
Other editions - View all
Common terms and phrases
apolipoprotein Association atherosclerosis baseline bill blood Capsules cardiovascular cent Chairman changes cholesterol cholesterol levels cholestyramine clofibrate Committee concentrations coronary heart disease decrease diabetic diet dose Drug Administration dyslipidaemic effect of gemfibrozil elevated fatty acid composition FDA approval Finland follow-up Food and Drug Framingham gemfibrozil treatment glucose HDL-cholesterol Health heart attacks Helsinki Heart Study hypercholesterolaemia hypertension incidence increase ischaemic heart disease Journal KASTENMEIER Kaukola laboratory legislation lipid lowering Lipid Research Clinics lipid-lowering lipoprotein cholesterol lipoprotein lipase lipoprotein lipase activity Lithell long-term Lopid Lopid patent low density lipoprotein LRC-CPPT male Manninen market exclusivity metabolism mmol/l mortality myocardial infarction Parke-Davis patent extension patent term extension patients pharmaceutical Phase IV study placebo Primary Prevention Trial ratio reduction regulatory risk factors Royal Society safety serum cholesterol serum lipid significant Society of Medicine Subcommittee Table Term Restoration Act therapy treatment groups triglycerides Vessby VLDL Warner-Lambert Waxman-Hatch
Popular passages
Page 113 - A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity, J.
Page 113 - Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Page 291 - Kagan A.: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
Page 73 - I am a partner in the Washington, DC law firm of Covington & Burling. I have been asked to present testimony on patent term restoration.
Page 341 - Five-year findings of the Hypertension Detection and Followup Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 244 - For the purposes of paragraph (2)(B), the term "due diligence" means that degree of attention, continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
Page 67 - HL-07182 from the National Heart, Lung and Blood Institute of the National Institutes of Health, and by the American Heart Association, Indiana Affiliate, Inc.
Page 8 - Mr. BOUCHER. Thank you very much, Mr. Chairman. I want to commend you...